Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  COVID-19

  Free Subscription


Articles published in Emerg Infect Dis

Retrieve available abstracts of 362 articles:
HTML format



Single Articles


    July 2025
  1. TARBUCK NN, Garushyants SK, McBride DS, Dennis PM, et al
    Persistence of SARS-CoV-2 Alpha Variant in White-Tailed Deer, Ohio, USA.
    Emerg Infect Dis. 2025;31:1319-1329.
    PubMed     Abstract available


  2. SU YCF, Zeller MA, Cronin P, Zhang R, et al
    Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, Singapore.
    Emerg Infect Dis. 2025;31.
    PubMed     Abstract available


    June 2025
  3. ROSAS IO, Benitez A, McKinnell JA, Shah R, et al
    Long-Term Clinical Outcomes of Adults Hospitalized for COVID-19 Pneumonia.
    Emerg Infect Dis. 2025;31:1158-1168.
    PubMed     Abstract available


    May 2025
  4. SPENCER BR, Akinseye A, Grebe E, Stone M, et al
    Self-Reported SARS-CoV-2 Infections among National Blood Donor Cohort, United States, 2020-2022.
    Emerg Infect Dis. 2025;31:1006-1009.
    PubMed     Abstract available


  5. GREBE E, Chacreton D, Stone M, Spencer BR, et al
    Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting.
    Emerg Infect Dis. 2025;31:958-966.
    PubMed     Abstract available


  6. PHAM K, Chaguza C, Lopes R, Cohen T, et al
    Large-Scale Genomic Analysis of SARS-CoV-2 Omicron BA.5 Emergence, United States.
    Emerg Infect Dis. 2025;31:45-56.
    PubMed     Abstract available


  7. FEISTEL DJ, Welsh R, Mercante J, Mark-Carew M, et al
    Detection and Tracking of SARS-CoV-2 Lineages through National Wastewater Surveillance System Pathogen Genomics.
    Emerg Infect Dis. 2025;31:57-60.
    PubMed     Abstract available


  8. EMMEN IE, Vuyk WC, Lail AJ, Wolf S, et al
    SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA.
    Emerg Infect Dis. 2025;31:61-69.
    PubMed     Abstract available


  9. FRIEDMAN CR, Morfino RC, Ernst ET
    Leveraging a Strategic Public-Private Partnership to Launch an Airport-Based Pathogen Monitoring Program to Detect Emerging Health Threats.
    Emerg Infect Dis. 2025;31:35-38.
    PubMed     Abstract available


  10. JULES E, Decker C, Bixler BJ, Ahmed A, et al
    Respiratory Virus Detection and Sequencing from SARS-CoV-2-Negative Rapid Antigen Tests.
    Emerg Infect Dis. 2025;31:39-44.
    PubMed     Abstract available


  11. MACCANNELL D, MacInnis B, Santibanez S, Honein MA, et al
    A Decade of Partnerships and Progress in Pathogen Genomics in Public Health Practice.
    Emerg Infect Dis. 2025;31:1-2.
    PubMed    


  12. MOORE J, Sanon R, Khudyakov Y, Barnes N, et al
    Strategies and Opportunities to Improve Community Health through Advanced Molecular Detection and Genomic Surveillance of Infectious Diseases.
    Emerg Infect Dis. 2025;31:9-13.
    PubMed     Abstract available


  13. FLOREK KR, Young EL, Incekara K, Libuit KG, et al
    Advantages of Software Containerization in Public Health Infectious Disease Genomic Surveillance.
    Emerg Infect Dis. 2025;31:18-21.
    PubMed     Abstract available


  14. PORTER WT, Engelthaler DM, Hepp CM
    Genomic Epidemiology for Estimating Pathogen Burden in a Population.
    Emerg Infect Dis. 2025;31:22-24.
    PubMed     Abstract available


    April 2025
  15. SANDER B, Mishra S, Swayze S, Sahakyan Y, et al
    Population-Based Matched Cohort Study of COVID-19 Healthcare Costs, Ontario, Canada.
    Emerg Infect Dis. 2025;31:710-719.
    PubMed     Abstract available


    March 2025
  16. BI K, Bandekar SR, Bouchnita A, Fox SJ, et al
    Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023-2024.
    Emerg Infect Dis. 2025;31:636-638.
    PubMed     Abstract available


  17. AGUILAR-BULTET L, Gomez-Sanz E, Garcia-Martin AB, Hug MA, et al
    Extended-Spectrum beta-Lactamase-Producing Enterobacterales in Municipal Wastewater Collections, Switzerland, 2019-2023.
    Emerg Infect Dis. 2025;31:574-578.
    PubMed     Abstract available


  18. LEBER AL, Embry T, Everhart K, Taveras J, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.
    Emerg Infect Dis. 2025;31:555-558.
    PubMed     Abstract available


    February 2025
  19. UJIIE M
    Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan.
    Emerg Infect Dis. 2025;31.
    PubMed     Abstract available


  20. FERREIRA FC, Pervin T, Tang WW, Hediger JA, et al
    Respiratory Shedding of Infectious SARS-CoV-2 Omicron XBB.1.41.1 Lineage among Captive White-Tailed Deer, Texas, USA.
    Emerg Infect Dis. 2025;31:267-274.
    PubMed     Abstract available


  21. DAVIES MA, de Gier B, Guy RL, Coelho J, et al
    Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England.
    Emerg Infect Dis. 2025;31:229-236.
    PubMed     Abstract available


    January 2025
  22. KITI MC, Sacoor C, Aguolu OG, Zelaya A, et al
    Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021-2022.
    Emerg Infect Dis. 2025;31:94-103.
    PubMed     Abstract available


  23. ENGELI V, Roussos S, Demiris N, Hatzakis A, et al
    Social Contact Patterns and Age Mixing before and during COVID-19 Pandemic, Greece, January 2020-October 2021.
    Emerg Infect Dis. 2025;31:75-85.
    PubMed     Abstract available


  24. MA J, Yang Y, Huang Y
    Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990-2022.
    Emerg Infect Dis. 2025;31:14-21.
    PubMed     Abstract available


    December 2024
  25. HASSAN AM, Muhlemann B, Al-Subhi TL, Rodon J, et al
    Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023-2024.
    Emerg Infect Dis. 2024;31.
    PubMed     Abstract available


    November 2024
  26. BRATCHER A, Kao SY, Chun K, Petropoulos CJ, et al
    Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and Neutralizing Antibody Titers in Previously Infected Persons, United States, January 2021-February 2022.
    Emerg Infect Dis. 2024;30:2352-2361.
    PubMed     Abstract available


  27. TAKAYAMA Y, Shimakawa Y, Matsuyama R, Chowell G, et al
    SARS-CoV-2 Infection in School Settings, Okinawa Prefecture, Japan, 2021-2022.
    Emerg Infect Dis. 2024;30:2343-2351.
    PubMed     Abstract available


  28. DING K, Naqvi OH, Seeberger RJ, Bratzler DW, et al
    Spatiotemporal Ecologic Analysis of COVID-19 Vaccination Coverage and Outcomes, Oklahoma, USA, February 2020-December 2021.
    Emerg Infect Dis. 2024;30:2333-2342.
    PubMed     Abstract available


  29. BURCKHARDT I, Burckhardt F
    Epidemiology of Streptococcus pyogenes Disease before, during, and after COVID-19 Pandemic, Germany, 2005-2023.
    Emerg Infect Dis. 2024;30:2435-2438.
    PubMed     Abstract available


  30. TINOCO YO, Osman TS, Ampuero JS, Gazo M, et al
    Respiratory Disease Surveillance in the Middle East and Latin America during the COVID-19 Pandemic, 2020-2022.
    Emerg Infect Dis. 2024;30:26-32.
    PubMed     Abstract available


  31. CREPPAGE KE, Gallaway MS, Russell DA, Early JM, et al
    Global Emerging Infections Surveillance Program Contributions to Pandemic Preparedness and Response.
    Emerg Infect Dis. 2024;30:9-12.
    PubMed     Abstract available


    October 2024
  32. YOON D, Jung K, Kim JH, Ko HY, et al
    Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021-2022.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  33. LININGER N, Falender R, Cieslak P, Novak A, et al
    Correlation between Viral Wastewater Concentration and Respiratory Tests, Oregon, USA.
    Emerg Infect Dis. 2024;30:2194-2196.
    PubMed     Abstract available


  34. WERNIKE K, Mehl C, Aebischer A, Ulrich L, et al
    SARS-CoV-2 and Other Coronaviruses in Rats, Berlin, Germany, 2023.
    Emerg Infect Dis. 2024;30:2205-2208.
    PubMed     Abstract available


  35. CHARLES H, Thorley K, Turner C, Bennet KF, et al
    Mpox Epidemiology and Vaccine Effectiveness, England, 2023.
    Emerg Infect Dis. 2024;30:2145-2148.
    PubMed     Abstract available


  36. ODUNDO EA, Kipkirui EC, Koech MC, Kirui MC, et al
    Azithromycin Resistance Patterns in Escherichia coli and Shigella before and after COVID-19, Kenya.
    Emerg Infect Dis. 2024;30:86-93.
    PubMed     Abstract available


  37. MORTON LC, Rahman N, Bishop-Lilly KA
    Next-Generation Sequencing and Bioinformatics Consortium Approach to Genomic Surveillance.
    Emerg Infect Dis. 2024;30:13-18.
    PubMed     Abstract available


    September 2024
  38. YU S, Yang T
    Non-HIV Immunocompetent Patient with COVID-19 and Severe Pneumocystis jirovecii Pneumonia Co-Infection.
    Emerg Infect Dis. 2024;30:1948-1952.
    PubMed     Abstract available


  39. LOENENBACH A, Lehfeld AS, Puetz P, Biere B, et al
    Participatory, Virologic, and Wastewater Surveillance Data to Assess Underestimation of COVID-19 Incidence, Germany, 2020-2024.
    Emerg Infect Dis. 2024;30:1939-1943.
    PubMed     Abstract available


  40. FOX SJ, Kim M, Meyers LA, Reich NG, et al
    Optimizing Disease Outbreak Forecast Ensembles.
    Emerg Infect Dis. 2024;30:1967-1969.
    PubMed     Abstract available


    August 2024
  41. KUCHARSKI AJ, Russell TW, Hellewell J, Funk S, et al
    SARS-CoV-2 Dynamics in the English Premier League Testing Program.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  42. SHI C, Zhang Y, Ye S, Zhou J, et al
    Infection Rates and Symptomatic Proportion of SARS-CoV-2 and Influenza in Pediatric Population, China, 2023.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  43. WU TH, Fang YP, Liu FC, Pan HH, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017-2023.
    Emerg Infect Dis. 2024;30:1692-1696.
    PubMed     Abstract available


  44. SHETH K, Hopkins L, Domakonda K, Stadler L, et al
    Wastewater Target Pathogens of Public Health Importance for Expanded Sampling, Houston, Texas, USA.
    Emerg Infect Dis. 2024;30:14-17.
    PubMed     Abstract available


  45. KANTONEN JN, Kuivanen S, Smura T, Puttonen H, et al
    Infective SARS-CoV-2 in Skull Sawdust at Autopsy, Finland.
    Emerg Infect Dis. 2024;30:1735-1737.
    PubMed     Abstract available


  46. MITSUSHIMA S, Yahata Y, Tsuchihashi Y, Ikenoue C, et al
    Fatal SARS-CoV-2 Infection among Children, Japan, January-September 2022(1).
    Emerg Infect Dis. 2024;30:1589-1598.
    PubMed     Abstract available


  47. PURVES K, Brown H, Haverty R, Ryan A, et al
    SARS-CoV-2 Seropositivity in Urban Population of Wild Fallow Deer, Dublin, Ireland, 2020-2022.
    Emerg Infect Dis. 2024;30:1609-1620.
    PubMed     Abstract available


    July 2024
  48. GREBE E, Stone M, Spencer BR, Akinseye A, et al
    Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  49. OGATA T, Tanaka H, Kon A, Sakaibori N, et al
    Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2-Dominant Period, Japan.
    Emerg Infect Dis. 2024;30:1430-1433.
    PubMed     Abstract available


  50. BARAK MEM, Wu S, Luria G, Schnyder LP, et al
    Engaging Communities in Emerging Infectious Disease Mitigation to Improve Public Health and Safety.
    Emerg Infect Dis. 2024;30:1390-1397.
    PubMed     Abstract available


  51. IBA A, Hosozawa M, Hori M, Muto Y, et al
    Prevalence of and Risk Factors for Post-COVID-19 Condition during Omicron BA.5-Dominant Wave, Japan.
    Emerg Infect Dis. 2024;30:1380-1389.
    PubMed     Abstract available


  52. FESS LJ, Fell A, O'Toole S, D'Heilly P, et al
    COVID-19 Death Determination Methods, Minnesota, USA, 2020-2022(1).
    Emerg Infect Dis. 2024;30:1352-1360.
    PubMed     Abstract available


  53. KIIZA D, Semanda JN, Kawere BB, Ajore C, et al
    Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda-Lessons Learned and Recommendations for Future Pandemics.
    Emerg Infect Dis. 2024;30:1326-1334.
    PubMed     Abstract available


    June 2024
  54. ALVAREZ-HERNANDEZ G, Rivera-Rosas CN, Calleja-Lopez JRT, McCormick DW, et al
    Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children, Sonora, Mexico.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  55. KINOSHITA R, Miyamoto S, Sakuraba S, Sugihara J, et al
    Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023.
    Emerg Infect Dis. 2024;30:1267-1270.
    PubMed     Abstract available


  56. CANO-TERRIZA D, Beato-Benitez A, Fernandez-Bastit L, Segales J, et al
    SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020-2023.
    Emerg Infect Dis. 2024;30:1253-1257.
    PubMed     Abstract available


  57. CERPAS C, Vasquez G, Moreira H, Juarez JG, et al
    Introduction of New Dengue Virus Lineages of Multiple Serotypes after COVID-19 Pandemic, Nicaragua, 2022.
    Emerg Infect Dis. 2024;30:1203-1213.
    PubMed     Abstract available


  58. CUNNINGHAM-OAKES E, Pilgrim J, Darby AC, Appleton C, et al
    Emerging Variants of Canine Enteric Coronavirus Associated with Outbreaks of Gastroenteric Disease.
    Emerg Infect Dis. 2024;30:1240-1244.
    PubMed     Abstract available


  59. BANKERS L, O'Brien SC, Tapay DM, Ho E, et al
    SARS-CoV-2 Disease Severity and Cycle Threshold Values in Children Infected during Pre-Delta, Delta, and Omicron Periods, Colorado, USA, 2021-2022.
    Emerg Infect Dis. 2024;30:1182-1192.
    PubMed     Abstract available


  60. GRIFFIN I, King J, Lyons BC, Singleton AL, et al
    Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States.
    Emerg Infect Dis. 2024;30:1144-1153.
    PubMed     Abstract available


  61. CHANG T, Cho SI, Yoo DS, Min KD, et al
    Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
    Emerg Infect Dis. 2024;30:1154-1163.
    PubMed     Abstract available


  62. COCOROS NM, Eberhardt K, Nguyen VT, Brown CM, et al
    Electronic Health Record-Based Algorithm for Monitoring Respiratory Virus-Like Illness.
    Emerg Infect Dis. 2024;30:1096-1103.
    PubMed     Abstract available


    May 2024
  63. LUSTIG Y, Canetti M, Indenbaum V, Peretz Y, et al
    SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.
    Emerg Infect Dis. 2024;30:1050-1052.
    PubMed     Abstract available


  64. MOUCHTOURI VA, Kourentis L, Anagnostopoulos L, Koureas M, et al
    Interventional Study of Nonpharmaceutical Measures to Prevent COVID-19 Aboard Cruise Ships.
    Emerg Infect Dis. 2024;30:1030-1033.
    PubMed     Abstract available


  65. KEHOE AD, Mallhi AK, Barton CR, Martin HM, et al
    SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020-January 2022.
    Emerg Infect Dis. 2024;30:956-967.
    PubMed     Abstract available


  66. YEE R, Carranza D, Kim C, Trinidad JP, et al
    COVID-19 Vaccination Site Accessibility, United States, December 11, 2020-March 29, 2022.
    Emerg Infect Dis. 2024;30:947-955.
    PubMed     Abstract available


  67. NOBLE BA, Jiudice SS, Jones JD, Timbrook TT, et al
    Reemergence of Bordetella parapertussis, United States, 2019-2023.
    Emerg Infect Dis. 2024;30:1058-1060.
    PubMed     Abstract available


  68. OPE M, Musyoka R, Kiogora J, Wambugu J, et al
    Epidemiology of SARS-CoV-2 in Kakuma Refugee Camp Complex, Kenya, 2020-2021(1).
    Emerg Infect Dis. 2024;30:900-907.
    PubMed     Abstract available


    April 2024
  69. DOI A, Ota M, Saito M, Matsuyama S, et al
    Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  70. NGUYENLA XH, Bates TA, Trank-Greene M, Wahedi M, et al
    Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  71. TANTIRAT P, Chantarawichian Y, Taweewigyakarn P, Kripattanapong S, et al
    Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021.
    Emerg Infect Dis. 2024;30:791-794.
    PubMed     Abstract available


  72. SOLER-IBORTE E, Rivera-Izquierdo M, Valero-Ubierna C
    Opportunistic Elizabethkingia miricola Infections in Intensive Care Unit, Spain.
    Emerg Infect Dis. 2024;30:834-837.
    PubMed     Abstract available


  73. SCHOLL M, Hohn C, Boucsein J, Moek F, et al
    Bus Riding as Amplification Mechanism for SARS-CoV-2 Transmission, Germany, 2021(1).
    Emerg Infect Dis. 2024;30:711-720.
    PubMed     Abstract available


  74. KENDIG NE, Bur S, Zaslavsky J
    Infection Prevention and Control in Correctional Settings.
    Emerg Infect Dis. 2024;30:S88-S93.
    PubMed     Abstract available


  75. PORTER LJ, Rapheal E, Huebsch R, Bastian T, et al
    Development and Evaluation of Surveillance System for Identifying Jail-Associated COVID-19 Cases in Minnesota, USA, 2022.
    Emerg Infect Dis. 2024;30:S28-S35.
    PubMed     Abstract available


  76. SABER LB, Kennedy SS, Yang Y, Moore KN, et al
    Correlation of SARS-CoV-2 in Wastewater and Individual Testing Results in a Jail, Atlanta, Georgia, USA.
    Emerg Infect Dis. 2024;30:S21-S27.
    PubMed     Abstract available


  77. HAGAN LM, Mosites E, Hughes-Baker L, Butler J, et al
    Carceral Health is Public Health.
    Emerg Infect Dis. 2024;30:S1-S4.
    PubMed    


  78. GURREY SO, Strick LB, Dov LK, Miller JS, et al
    Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
    Emerg Infect Dis. 2024;30:S17-S20.
    PubMed     Abstract available


  79. WADDELL C, Meehan A, Schoonveld M, Kaplan Z, et al
    Lessons Learned from COVID-19 Response in Correctional and Detention Facilities.
    Emerg Infect Dis. 2024;30:S5-S12.
    PubMed     Abstract available


  80. TUNSTALL AM, O'Brien SC, Monaghan DM, Burakoff A, et al
    Lessons Learned from Cross-Systems Approach to COVID-19 Pandemic Response in Juvenile Justice System, Colorado, USA.
    Emerg Infect Dis. 2024;30:S13-S16.
    PubMed     Abstract available


    March 2024
  81. PATERSON A, Cheyne A, Jones B, Schilling S, et al
    Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.
    Emerg Infect Dis. 2024;30:519-529.
    PubMed     Abstract available


  82. OGOTI BM, Riitho V, Wildemann J, Mutono N, et al
    Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023.
    Emerg Infect Dis. 2024;30:581-585.
    PubMed     Abstract available


  83. VU QM, Fitzpatrick AL, Cope JR, Bertolli J, et al
    Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2024;30:539-547.
    PubMed     Abstract available


  84. KECK JW, Adatorwovor R, Liversedge M, Mijotavich B, et al
    Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021-2022.
    Emerg Infect Dis. 2024;30:530-538.
    PubMed     Abstract available


  85. VON MOLLENDORF C, Ulziibayar M, Nguyen CD, Batsaikhan P, et al
    Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021.
    Emerg Infect Dis. 2024;30:490-498.
    PubMed     Abstract available


    February 2024
  86. HODGES NF, Sparrer M, Sherman T, Mayer T, et al
    Integrating Veterinary Diagnostic Laboratories for Emergency Use Testing during Pandemics(1).
    Emerg Infect Dis. 2024;30:386-388.
    PubMed     Abstract available


  87. TAKEMURA T, Ankhanbaatar U, Settypalli TBK, Purevtseren D, et al
    SARS-CoV-2 Infection in Beaver Farm, Mongolia, 2021.
    Emerg Infect Dis. 2024;30:391-394.
    PubMed     Abstract available


  88. TORI ME, Chontos-Komorowski J, Stacy J, Lamson DM, et al
    Identification of Large Adenovirus Infection Outbreak at University by Multipathogen Testing, South Carolina, USA, 2022.
    Emerg Infect Dis. 2024;30:358-362.
    PubMed     Abstract available


  89. PORTER SM, Hartwig AE, Bielefeldt-Ohmann H, Marano JM, et al
    Experimental SARS-CoV-2 Infection of Elk and Mule Deer.
    Emerg Infect Dis. 2024;30:354-357.
    PubMed     Abstract available


  90. JUSTMAN J, Skalland T, Moore A, Amos CI, et al
    Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021(1).
    Emerg Infect Dis. 2024;30:245-254.
    PubMed     Abstract available


    January 2024
  91. LEE CY, Kuo HW, Liu YL, Chuang JH, et al
    Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  92. CHAVES TDSS, Perosa AH, Barbosa G, Ferreira DB, et al
    Betacoronavirus Infection Outbreak, Sao Paulo, Brazil, Fall 2023.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  93. EGBELOWO OF, Fox SJ, Gibson GC, Meyers LA, et al
    Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  94. EALES O, Plank MJ, Cowling BJ, Howden BP, et al
    Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  95. JEON S, Watson-Lewis L, Rainisch G, Chiu CC, et al
    Adapting COVID-19 Contact Tracing Protocols to Accommodate Resource Constraints, Philadelphia, Pennsylvania, USA, 2021.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  96. BAI Y, Du Z, Wang L, Lau EHY, et al
    Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  97. FOUNTAIN H, Migchelsen SJ, Charles H, Ram T, et al
    Rebound of Gonorrhea after Lifting of COVID-19 Preventive Measures, England.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  98. ZHAO S, Mok CKP, Tang YS, Chen C, et al
    Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  99. RECTOR A, Bloemen M, Thijssen M, Pussig B, et al
    Respiratory Viruses in Wastewater Compared with Clinical Samples, Leuven, Belgium.
    Emerg Infect Dis. 2024;30:141-145.
    PubMed     Abstract available


  100. HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al
    Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020.
    Emerg Infect Dis. 2024;30:136-140.
    PubMed     Abstract available


  101. OGATA T, Tanaka H
    SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response).
    Emerg Infect Dis. 2024;30:207.
    PubMed    


  102. CHENG HY, Akhmetzhanov AR, Dushoff J
    SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan.
    Emerg Infect Dis. 2024;30:206-207.
    PubMed    


  103. MUEHLEMAN D, Gruner B, Hogan V, Fanning P, et al
    Using SARS-CoV-2 Sequencing Data to Identify Reinfection Cases in the Global Emerging Infections Surveillance Program, United States.
    Emerg Infect Dis. 2024;30:53-61.
    PubMed     Abstract available


    December 2023
  104. ZVIEDRITE N, Jahan F, Moreland S, Ahmed F, et al
    COVID-19-Related School Closures, United States, July 27, 2020-June 30, 2022.
    Emerg Infect Dis. 2023;30.
    PubMed     Abstract available


  105. ZANELLA MC, Pianca E, Catho G, Obama B, et al
    Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland.
    Emerg Infect Dis. 2023;30.
    PubMed     Abstract available


  106. CHEUNG YYH, Lau EHY, Yin G, Lin Y, et al
    Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong.
    Emerg Infect Dis. 2023;30.
    PubMed     Abstract available


    November 2023
  107. ANDREIS TF, Cantarelli VV, da Silva MB, Helfer MS, et al
    Substantial Diversity in Cocirculating Omicron Lineages in Hospital Setting, Porto Alegre, Brazil.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  108. AHMED F, Nowalk MP, Zimmerman RK, Bear T, et al
    Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  109. PATEL S, Cumming F, Mayers C, Charlett A, et al
    Simulation Study of Surveillance Strategies for Faster Detection of Novel SARS-CoV-2 Variants.
    Emerg Infect Dis. 2023;29:2292-2297.
    PubMed     Abstract available


  110. TERAN RA, Gagner A, Gretsch S, Lauritsen J, et al
    SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.
    Emerg Infect Dis. 2023;29:2257-2265.
    PubMed     Abstract available


  111. KIM DH, Kim DY, Kim KS, Han SH, et al
    Neurologic Effects of SARS-CoV-2 Transmitted among Dogs.
    Emerg Infect Dis. 2023;29:2275-2284.
    PubMed     Abstract available


  112. ARCARI G, Cecilia F, Oliva A, Polani R, et al
    Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy.
    Emerg Infect Dis. 2023;29:2266-2274.
    PubMed     Abstract available


    October 2023
  113. QVESEL AG, Bennedbaek M, Larsen NB, Gunalan V, et al
    SARS-CoV-2 Variants BQ.1 and XBB.1.5 in Wastewater of Aircraft Flying from China to Denmark, 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  114. XIONG W, Cowling BJ, Tsang TK
    Influenza Resurgence after Relaxation of Public Health and Social Measures, Hong Kong, 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  115. IP YCA, Tan A, Ong J, Fernandez CJ, et al
    Anthropogenic Transmission of SARS-CoV-2 from Humans to Lions, Singapore, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  116. KURIBAYASHI ST, Kasamatsu A, Ikenoue C, Fukusumi M, et al
    SARS-CoV-2 Infection in Wrestlers after International Tournaments, April 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  117. HYAMS C, Challen R, Hettle D, Amin-Chowdhury Z, et al
    Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006?2022.
    Emerg Infect Dis. 2023;29:1953-64.
    PubMed     Abstract available


    September 2023
  118. MWANGA MJ, Lambisia AW, Morobe JM, Murunga N, et al
    New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  119. HARRISON RE, Hamada A, Haswell N, Groves A, et al
    Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  120. LAMPROS A, Talla C, Diarra M, Tall B, et al
    Shifting Patterns of Influenza Circulation during the COVID-19 Pandemic, Senegal.
    Emerg Infect Dis. 2023;29:1808-1817.
    PubMed     Abstract available


  121. BELLIZZI S, Letchford N, Adib K, Probert WJM, et al
    Participatory Mathematical Modeling Approach for Policymaking during the First Year of the COVID-19 Crisis, Jordan.
    Emerg Infect Dis. 2023;29:1738-1746.
    PubMed     Abstract available


    August 2023
  122. NABITY SA, Marks SM, Goswami ND, Smith SR, et al
    Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  123. MNDALA L, Chapuma C, Riches J, Gadama L, et al
    Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  124. CHAN YLE, Irvine MA, Prystajecky N, Sbihi H, et al
    Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  125. DU Z, Wang Y, Bai Y, Wang L, et al
    Estimate of COVID-19 Deaths, China, December 2022-February 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  126. ANDRONESCU LR, Richard SA, Laing ED, Pisanic N, et al
    Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  127. MOONAN PK, Smith JP, Borah BF, Vohra D, et al
    Home-Based Testing and COVID-19 Isolation Recommendations, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  128. FALENDER RA, Mitchell PG, Guzman-Cottrill JA, Cieslak PR, et al
    Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020-June 30, 2022.
    Emerg Infect Dis. 2023;29:1672-1675.
    PubMed     Abstract available


  129. HECHT G, Dale AP, Ruberto I, Adame G, et al
    Detection of Hantavirus during the COVID-19 Pandemic, Arizona, USA, 2020.
    Emerg Infect Dis. 2023;29:1663-1667.
    PubMed     Abstract available


  130. TOOMRE D, Kandula S, Shaman J
    Longitudinal Association of COVID-19 Hospitalization and Death with Online Search for Loss of Smell or Taste.
    Emerg Infect Dis. 2023;29:1711-1713.
    PubMed     Abstract available


  131. YOO BK, Iwamoto R, Chung U, Sasaki T, et al
    Economic Evaluation of Wastewater Surveillance Combined with Clinical COVID-19 Screening Tests, Japan.
    Emerg Infect Dis. 2023;29:1608-1617.
    PubMed     Abstract available


  132. MANGIONI D, Chatenoud L, Colombo J, Palomba E, et al
    Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients(1).
    Emerg Infect Dis. 2023;29:1598-1607.
    PubMed     Abstract available


  133. MCMANUS O, Christiansen LE, Nauta M, Krogsgaard LW, et al
    Predicting COVID-19 Incidence Using Wastewater Surveillance Data, Denmark, October 2021-June 2022.
    Emerg Infect Dis. 2023;29:1589-1597.
    PubMed     Abstract available


    July 2023
  134. NEWELL K, Fischer M, Massey S, Orell L, et al
    Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020-2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  135. KINOSHITA R, Arashiro T, Kitamura N, Arai S, et al
    Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  136. ATHERSTONE CJ, Guagliardo SAJ, Hawksworth A, O'Laughlin K, et al
    COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020-2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  137. TSANG TK, Huang X, Fong MW, Wang C, et al
    Effects of School-Based Preventive Measures on COVID-19 Incidence, Hong Kong, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  138. KUSAMA T, Takeuchi K, Tamada Y, Kiuchi S, et al
    Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020-2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  139. EILERS B, Adelbai-Fraser MD, Collado JR, Van Dyke M, et al
    Patient Characteristics During Early Transmission of SARS-CoV-2, Palau, January 13-February 24, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  140. GOLD JAW, Adjei S, Gundlapalli AV, Huang YA, et al
    Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021.
    Emerg Infect Dis. 2023;29:1433-1437.
    PubMed     Abstract available


  141. RUDRAMURTHY SM, Singh S, Kanaujia R, Chaudhary H, et al
    Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus.
    Emerg Infect Dis. 2023;29:1313-1322.
    PubMed     Abstract available


  142. BIRAN R, Cohen R, Finn T, Brosh-Nissimov T, et al
    Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022(1).
    Emerg Infect Dis. 2023;29:1297-1301.
    PubMed     Abstract available


    June 2023
  143. ROWE D, McDermott C, Veliz Y, Kerr A, et al
    Dengue Outbreak Response during COVID-19 Pandemic, Key Largo, Florida, USA, 2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  144. CHENG L, Dhiyebi HA, Varia M, Atanas K, et al
    Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  145. BERTRAM R, Hitzl W, Steinmann E, Steinmann J, et al
    Asymptomatic Healthcare Worker PCR Screening during SARS-CoV-2 Omicron Surge, Germany, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  146. MIYAHARA R, Tamura K, Kato T, Nakazaki M, et al
    SARS-CoV-2 Variants and Age-Dependent Infection Rates among Household and Nonhousehold Contacts.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  147. JACOB RA, Zhang A, Ajoge HO, D'Agostino MR, et al
    Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  148. OTAKE S, Ikenoue C, Sudani N, Kobayashi M, et al
    National Surveillance of Pediatric Acute Hepatitis of Unknown Etiology, Japan, October 2021-December 2022.
    Emerg Infect Dis. 2023;29:1288-1291.
    PubMed     Abstract available


  149. MEYER ZU NATRUP C, Schunemann LM, Saletti G, Clever S, et al
    MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination.
    Emerg Infect Dis. 2023;29:1236-1239.
    PubMed     Abstract available


    May 2023
  150. FERRARI M, Di Marco L, Pivetti A, Paduano S, et al
    Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  151. HAYNES JM, Dodd RY, Crowder LA, Notari EP, et al
    Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  152. BLOOMFIELD LE, Ngeh S, Cadby G, Hutcheon K, et al
    SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  153. TYSON GB, Jones S, Logan N, McDonald M, et al
    SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  154. GROENHEIT R, Bacchus P, Galanis I, Sonden K, et al
    High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  155. RODRIGUEZ-GRANDE C, Estevez A, Palomino-Cabrera R, Molero-Salinas A, et al
    Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  156. OKAFOR CM, Clogher P, Olson D, Niccolai L, et al
    Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  157. BAE J, Ro C, Kang Y, Ga E, et al
    Human-to-Animal Transmission of SARS-CoV-2, South Korea, 2021.
    Emerg Infect Dis. 2023;29:1066-1067.
    PubMed     Abstract available


    April 2023
  158. BARROSO-AREVALO S, Sanchez-Morales L, Barasona JA, Dominguez L, et al
    SARS-CoV-2 Seroprevalence Studies in Pets, Spain.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  159. SIEGRIST AA, Richardson KL, Ghai RR, Pope B, et al
    Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  160. TURNER S, Alisoltani A, Bratt D, Cohen-Lavi L, et al
    US National Institutes of Health Prioritization of SARS-CoV-2 Variants.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  161. BUSHMAKER T, Yinda CK, Morris DH, Holbrook MG, et al
    Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  162. ASAKURA T, Kimura T, Kurotori I, Kenichi K, et al
    Case-Control Study of Long COVID, Sapporo, Japan.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  163. GIDDING HF, Stepien S, Qian J, Macartney KK, et al
    COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  164. TAM NT, Anh NT, Tung TS, Thach PN, et al
    Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  165. STAMOS DB, Barajas-Ochoa A, Raybould JE
    Nocardia pseudobrasiliensis Co-infection in SARS-CoV-2 Patients.
    Emerg Infect Dis. 2023;29:696-700.
    PubMed     Abstract available


  166. ADU B, Bonney JHK, Egyir B, Otchere ID, et al
    SARS-CoV-2 Molecular Evolutionary Dynamics in the Greater Accra Region, Ghana.
    Emerg Infect Dis. 2023;29:862-865.
    PubMed     Abstract available


    March 2023
  167. PAMPATI S, Rasberry CN, Timpe Z, McConnell L, et al
    Disparities in Implementing COVID-19 Prevention Strategies in Public Schools, United States, 2021-22 School Year.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  168. O'BRIEN SC, Cole LD, Albanese BA, Mahon A, et al
    SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May-July 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  169. SHAO PL, Tu HC, Gong YN, Shu HY, et al
    Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  170. WILSON WW, Keaton AA, Ochoa LG, Hatfield KM, et al
    Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021-March 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  171. BISOFFI Z, De Santis N, Piubelli C, Deiana M, et al
    Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  172. SANTIAGO GA, Volkman HR, Flores B, Gonzalez GL, et al
    SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  173. GARCIA-GARCIA ML, Perez-Arenas E, Perez-Hernandez P, Falces-Romero I, et al
    Human Metapneumovirus Infections during COVID-19 Pandemic, Spain.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  174. GOYA S, Sereewit J, Pfalmer D, Nguyen TV, et al
    Genomic Characterization of Respiratory Syncytial Virus during 2022-23 Outbreak, Washington, USA.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  175. ZENG K, Santhya S, Soong A, Malhotra N, et al
    Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  176. GLATMAN-FREEDMAN A, Hershkovitz Y, Dichtiar R, Rosenberg A, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5-11 Years of Age, Israel.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  177. BUI VN, Dao TD, Tran LH, Vu TT, et al
    SARS-CoV-2 Infection in a Hippopotamus, Hanoi, Vietnam.
    Emerg Infect Dis. 2023;29:658-661.
    PubMed     Abstract available


  178. FARFOUR E, Zrounba M, Roux A, Revillet H, et al
    Inquilinus limosus Bacteremia in Lung Transplant Recipient after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2023;29:642-644.
    PubMed     Abstract available


  179. STOFFELLA-DUTRA AG, de Campos BH, Bastos E Silva PH, Dias KL, et al
    SARS-CoV-2 Spillback to Wild Coatis in Sylvatic-Urban Hotspot, Brazil.
    Emerg Infect Dis. 2023;29:664-667.
    PubMed     Abstract available


  180. RODON J, Mykytyn AZ, Te N, Okba NMA, et al
    Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain.
    Emerg Infect Dis. 2023;29:585-589.
    PubMed     Abstract available


    February 2023
  181. LYOO KS, Lee H, Lee SG, Yeom M, et al
    Experimental Infection and Transmission of SARS-CoV-2 Delta and Omicron Variants among Beagle Dogs.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  182. VEENSTRA T, van Schelven PD, Ten Have YM, Swaan CM, et al
    Extensive Spread of SARS-CoV-2 Delta Variant among Vaccinated Persons during 7-Day River Cruise, the Netherlands.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  183. NILLES EJ, de St Aubin M, Dumas D, Duke W, et al
    Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021-August 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  184. OGATA T, Tanaka H
    SARS-CoV-2 Incubation Period during the Omicron BA.5-Dominant Period in Japan.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  185. PASCO R, Johnson K, Fox SJ, Pierce KA, et al
    COVID-19 Test Allocation Strategy to Mitigate SARS-CoV-2 Infections across School Districts.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  186. LAGATHU G, Grolhier C, Besombes J, Maillard A, et al
    Using Discarded Facial Tissues to Monitor and Diagnose Viral Respiratory Infections.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  187. HEINRICH F, Huter T, Mertens S, Lange P, et al
    New Postmortem Perspective on Emerging SARS-CoV-2 Variants of Concern, Germany.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  188. KISLAYA I, Casaca P, Borges V, Sousa C, et al
    Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  189. SOTO RA, Baldry E, Vahey GM, Lehman J, et al
    Increase in Colorado Tick Fever Virus Disease Cases and Effect of COVID-19 Pandemic on Behaviors and Testing Practices, Montana, 2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  190. KISLAYA I, Melo A, Barreto M, Henriques C, et al
    Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April-June 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  191. LIU D, Cheng Y, Zhou H, Wang L, et al
    Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA.
    Emerg Infect Dis. 2023;29:371-380.
    PubMed     Abstract available


  192. KHOURY DS, Schlub TE, Cromer D, Steain M, et al
    Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection.
    Emerg Infect Dis. 2023;29:381-388.
    PubMed     Abstract available


  193. OYGAR PD, Gurlevik SL, Sag E, Ilbay S, et al
    Changing Disease Course of Crimean-Congo Hemorrhagic Fever in Children, Turkey.
    Emerg Infect Dis. 2023;29:268-277.
    PubMed     Abstract available


    January 2023
  194. LANDRY M, Bornstein S, Nagaraj N, Sardon GA Jr, et al
    Postacute Sequelae of SARS-CoV-2 in University Setting.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  195. ELLINGSON KD, Hollister J, Porter CJ, Khan SM, et al
    Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  196. XIONG W, Peng L, Tsang TK, Cowling BJ, et al
    Epidemiology of SARS-CoV-2 Omicron BA.5 Infections, Macau, June-July 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  197. JEON S, Rainisch G, Harris AM, Shinabery J, et al
    Estimated Cases Averted by COVID-19 Digital Exposure Notification, Pennsylvania, USA, November 8, 2020-January 2, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  198. OFORI SK, Schwind JS, Sullivan KL, Chowell G, et al
    Age-Stratified Model to Assess Health Outcomes of COVID-19 Vaccination Strategies, Ghana.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  199. SHAFER L, Ahmed F, Kim S, Wernli KJ, et al
    Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  200. OLTEAN HN, Allen KJ, Frisbie L, Lunn SM, et al
    Sentinel Surveillance System Implementation and Evaluation for SARS-CoV-2 Genomic Data, Washington, USA, 2020-2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  201. ZAIDI A, Harris R, Hall J, Woodhall S, et al
    Effects of Second Dose of SARS-CoV-2 Vaccination on Household Transmission, England.
    Emerg Infect Dis. 2023;29:127-132.
    PubMed     Abstract available


  202. MUGISHA J, Mpairwe B, Newton R, Cotten M, et al
    SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda.
    Emerg Infect Dis. 2023;29:224-226.
    PubMed     Abstract available


  203. CURTIS SJ, Shah AW, Ratu A, Wilson DJ, et al
    Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021.
    Emerg Infect Dis. 2023;29:226-228.
    PubMed     Abstract available


  204. DEWITT ME, Tjaden AH, Herrington D, Schieffelin J, et al
    COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA.
    Emerg Infect Dis. 2023;29:207-211.
    PubMed     Abstract available


  205. MUTHU V, Agarwal R, Rudramurthy SM, Thangaraju D, et al
    Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
    Emerg Infect Dis. 2023;29:8-19.
    PubMed    


  206. KOKS-LEENSEN MCJ, Schalk BWM, Bakker-van Gijssel EJ, Timen A, et al
    Risk for Severe COVID-19 Outcomes among Persons with Intellectual Disabilities, the Netherlands.
    Emerg Infect Dis. 2023;29:118-126.
    PubMed     Abstract available


  207. MUNYEKU-BAZITAMA Y, Folefack GT, Yambayamba MK, Tshiminyi PM, et al
    High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo.
    Emerg Infect Dis. 2023;29:89-97.
    PubMed     Abstract available


  208. LEUNG C, Su L, Simoes-E-Silva AC, Arocha LS, et al
    Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil.
    Emerg Infect Dis. 2023;29:26-35.
    PubMed     Abstract available


  209. ROE MK, Huffman ER, Batista YS, Papadeas GG, et al
    Comprehensive Review of Emergence and Virology of Tickborne Bourbon Virus in the United States.
    Emerg Infect Dis. 2023;29:1-7.
    PubMed     Abstract available


    December 2022
  210. CLICK ES, Malec D, Chevinsky J, Tao G, et al
    Longitudinal Analysis of Electronic Health Information to Identify Possible COVID-19 Sequelae.
    Emerg Infect Dis. 2022;29.
    PubMed     Abstract available


  211. LU PJ, Srivastav A, Vashist K, Black CL, et al
    COVID-19 Booster Dose Vaccination Coverage and Factors associated with Booster Vaccination among Adults, United States, March 2022.
    Emerg Infect Dis. 2022;29.
    PubMed     Abstract available


  212. MURAKAMI S, Kitamura T, Matsugo H, Kamiki H, et al
    Isolation of Bat Sarbecoviruses, Japan.
    Emerg Infect Dis. 2022;28:2500-2503.
    PubMed     Abstract available


  213. EARNEST R, Chen C, Chaguza C, Hahn AM, et al
    Daily Rapid Antigen Exit Testing to Tailor University COVID-19 Isolation Policy.
    Emerg Infect Dis. 2022;28:2455-2462.
    PubMed     Abstract available


  214. FOULKES S, Monk EJM, Sparkes D, Hettiarachchi N, et al
    Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022.
    Emerg Infect Dis. 2022;29.
    PubMed     Abstract available


  215. KIMANI D, Ndegwa L, Njeru M, Wesangula E, et al
    Adopting World Health Organization Multimodal Infection Prevention and Control Strategies to Respond to COVID-19, Kenya.
    Emerg Infect Dis. 2022;28:S247-S254.
    PubMed     Abstract available


  216. BOBO P, Hines JZ, Chilengi R, Auld AF, et al
    Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia.
    Emerg Infect Dis. 2022;28:S244-S246.
    PubMed     Abstract available


  217. PECK ME, Ong KS, Lucas T, Prainito A, et al
    Effects of COVID-19 Pandemic on Voluntary Medical Male Circumcision Services for HIV Prevention, Sub-Saharan Africa, 2020.
    Emerg Infect Dis. 2022;28:S262-S269.
    PubMed     Abstract available


  218. ARRIOLA CS, Soto G, Westercamp M, Bollinger S, et al
    Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru.
    Emerg Infect Dis. 2022;28:S238-S243.
    PubMed     Abstract available


  219. IHEKWEAZU C
    Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S299-S301.
    PubMed     Abstract available


  220. MARCENAC P, McCarron M, Davis W, Igboh LS, et al
    Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S26-S33.
    PubMed     Abstract available


  221. OCHIENG W, Sage EO, Achia T, Oluoch P, et al
    Sexual Violence Trends before and after Rollout of COVID-19 Mitigation Measures, Kenya.
    Emerg Infect Dis. 2022;28:S270-S276.
    PubMed     Abstract available


  222. OLSON D, Calvimontes DM, Lamb MM, Guzman G, et al
    Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala(1).
    Emerg Infect Dis. 2022;28:S277-S287.
    PubMed     Abstract available


  223. AHERON S, Victory KR, Imtiaz A, Fellows I, et al
    A Nationally Representative Survey of COVID-19 in Pakistan, 2021-2022.
    Emerg Infect Dis. 2022;28:S69-S75.
    PubMed     Abstract available


  224. KINKADE C, Russpatrick S, Potter R, Saebo J, et al
    Extending and Strengthening Routine DHIS2 Surveillance Systems for COVID-19 Responses in Sierra Leone, Sri Lanka, and Uganda.
    Emerg Infect Dis. 2022;28:S42-S48.
    PubMed     Abstract available


  225. MIRZA M, Grant-Greene Y, Valles MPJS, Joseph P, et al
    Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response.
    Emerg Infect Dis. 2022;28:S49-S58.
    PubMed     Abstract available


  226. SHIH DC, Silver R, Henao OL, Alemu A, et al
    Incorporating COVID-19 into Acute Febrile Illness Surveillance Systems, Belize, Kenya, Ethiopia, Peru, and Liberia, 2020-2021.
    Emerg Infect Dis. 2022;28:S34-S41.
    PubMed     Abstract available


  227. SHRAGAI T, Talley L, Summers A, Behringer H, et al
    Outcomes after Acute Malnutrition Program Adaptations to COVID-19, Uganda, Ethiopia, and Somalia.
    Emerg Infect Dis. 2022;28:S288-S298.
    PubMed     Abstract available


  228. ROMANO ER, Sleeman K, Hall-Eidson P, Zeh C, et al
    Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries.
    Emerg Infect Dis. 2022;28:S59-S68.
    PubMed     Abstract available


  229. THEU JA, Kabaghe AN, Bello G, Chitsa-Banda E, et al
    SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020.
    Emerg Infect Dis. 2022;28:S76-S84.
    PubMed     Abstract available


  230. RICKS PM, Njie GJ, Dawood FS, Blain AE, et al
    Lessons Learned from CDC's Global COVID-19 Early Warning and Response Surveillance System.
    Emerg Infect Dis. 2022;28:S8-S16.
    PubMed     Abstract available


  231. OHLSEN EC, Hawksworth AW, Wong K, Guagliardo SAJ, et al
    Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions.
    Emerg Infect Dis. 2022;28:S85-S92.
    PubMed     Abstract available


  232. CASSELL CH, Raghunathan PL, Henao O, Pappas-DeLuca KA, et al
    Global Responses to the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S4-S7.
    PubMed    


  233. AMPONSA-ACHIANO K, Frimpong JA, Barradas D, Bandoh DA, et al
    Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021.
    Emerg Infect Dis. 2022;28:S232-S237.
    PubMed     Abstract available


  234. BIGOUETTE JP, Callaghan AW, Donadel M, Porter AM, et al
    Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020.
    Emerg Infect Dis. 2022;28:S203-S207.
    PubMed     Abstract available


  235. DIXON MG, Reef SE, Zimmerman LA, Grant GB, et al
    Past as Prologue-Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination.
    Emerg Infect Dis. 2022;28:S225-S231.
    PubMed     Abstract available


  236. HERMAN-ROLOFF A, Aman R, Samandari T, Kasera K, et al
    Adapting Longstanding Public Health Collaborations between Government of Kenya and CDC Kenya in Response to the COVID-19 Pandemic, 2020-2021.
    Emerg Infect Dis. 2022;28:S159-S167.
    PubMed     Abstract available


  237. MERRILL RD, Kilamile F, White M, Eurien D, et al
    Using Population Mobility Patterns to Adapt COVID-19 Response Strategies in 3 East Africa Countries.
    Emerg Infect Dis. 2022;28:S105-S113.
    PubMed     Abstract available


  238. GOMES DJ, Hazim C, Safstrom J, Herzig C, et al
    Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East Africa.
    Emerg Infect Dis. 2022;28:S255-S261.
    PubMed     Abstract available


  239. KABORE HJ, Li X, Allison RD, Avagyan T, et al
    Effects of Decreased Immunization Coverage for Hepatitis B Virus Caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020.
    Emerg Infect Dis. 2022;28:S217-S224.
    PubMed     Abstract available


  240. SMITH-SREEN J, Miller B, Kabaghe AN, Kim E, et al
    Comparison of COVID-19 Pandemic Waves in 10 Countries in Southern Africa, 2020-2021.
    Emerg Infect Dis. 2022;28:S93-S104.
    PubMed     Abstract available


  241. SINGH SK, Dikid T, Dhuria M, Bahl A, et al
    India Field Epidemiology Training Program Response to COVID-19 Pandemic, 2020-2021.
    Emerg Infect Dis. 2022;28:S138-S144.
    PubMed     Abstract available


  242. DOKUBO EK, Shang JD, N'Dir A, Ndongmo CB, et al
    Building on Capacity Established through US Centers for Disease Control and Prevention Global Health Programs to Respond to COVID-19, Cameroon.
    Emerg Infect Dis. 2022;28:S181-S190.
    PubMed     Abstract available


  243. ERICKSON-MAMANE L, Kryshchuk A, Gvozdetska O, Rossovskyi D, et al
    Faith Community Engagement to Mitigate COVID-19 Transmission Associated with Mass Gathering, Uman, Ukraine, September 2021.
    Emerg Infect Dis. 2022;28:S197-S202.
    PubMed     Abstract available


  244. KENU E, Barradas DT, Bandoh DA, Frimpong JA, et al
    Community-Based Surveillance and Geographic Information System‒Linked Contact Tracing in COVID-19 Case Identification, Ghana, March‒June 2020.
    Emerg Infect Dis. 2022;28:S114-S120.
    PubMed     Abstract available


  245. BOLU O, Mustapha B, Ihekweazu C, Muhammad M, et al
    Effect of Nigeria Presidential Task Force on COVID-19 Pandemic, Nigeria.
    Emerg Infect Dis. 2022;28:S168-S176.
    PubMed     Abstract available


  246. CHIOU H, Voegeli C, Wilhelm E, Kolis J, et al
    The Future of Infodemic Surveillance as Public Health Surveillance.
    Emerg Infect Dis. 2022;28:S121-S128.
    PubMed     Abstract available


  247. ZUBER A, Sebeh Y, Jarvis D, Bratton S, et al
    Exploratory Literature Review of the Role of National Public Health Institutes in COVID-19 Response.
    Emerg Infect Dis. 2022;28:S151-S158.
    PubMed     Abstract available


  248. BELL E, Mittendorf C, Meyer E, Barnum O, et al
    Continuing Contributions of Field Epidemiology Training Programs to Global COVID-19 Response.
    Emerg Infect Dis. 2022;28:S129-S137.
    PubMed     Abstract available


  249. WRIGHT J, Tison L, Chun H, Gutierrez C, et al
    Use of Project ECHO in Response to COVID-19 in Countries Supported by US President's Emergency Plan for AIDS Relief.
    Emerg Infect Dis. 2022;28:S191-S196.
    PubMed     Abstract available


  250. KNUST B, Wongjindanon N, Moe AA, Herath L, et al
    Enhancing Respiratory Disease Surveillance to Detect COVID-19 in Shelters for Displaced Persons, Thailand-Myanmar Border, 2020-2021.
    Emerg Infect Dis. 2022;28:S17-S25.
    PubMed     Abstract available


  251. SOETERS HM, Doshi RH, Fleming M, Adegoke OJ, et al
    CDC's COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions.
    Emerg Infect Dis. 2022;28:S208-S216.
    PubMed     Abstract available


  252. TABACK-ESRA R, Morof D, Briggs-Hagen M, Savva H, et al
    Use of Epidemiology Surge Support to Enhance Robustness and Expand Capacity of SARS-CoV-2 Pandemic Response, South Africa.
    Emerg Infect Dis. 2022;28:S177-S180.
    PubMed     Abstract available


  253. KRISHNAN S, Espinosa C, Podgornik MN, Haile S, et al
    COVID-19 Response Roles among CDC International Public Health Emergency Management Fellowship Graduates.
    Emerg Infect Dis. 2022;28:S145-S150.
    PubMed     Abstract available


  254. WALENSKY RP
    Partnerships, Collaborations, and Investments Integral to CDC's International Response to COVID-19.
    Emerg Infect Dis. 2022;28:S1-S3.
    PubMed    


    November 2022
  255. PEDERSEN RM, Bang LL, Tornby DS, Madsen LW, et al
    Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  256. WEI HY, Chang CP, Liu MT, Mu JJ, et al
    Probable Aerosol Transmission of SARS-CoV-2 through Floors and Walls of Quarantine Hotel, Taiwan, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  257. BOURRET V, Dutra L, Alburkat H, Maki S, et al
    Serologic Surveillance for SARS-CoV-2 Infection among Wild Rodents, Europe.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  258. THOMAS GR, Corso A, Pasteran F, Shal J, et al
    Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:1-8.
    PubMed     Abstract available


  259. QUINTERO AM, Eisner M, Sayegh R, Wright T, et al
    Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant.
    Emerg Infect Dis. 2022;28:2270-2280.
    PubMed     Abstract available


    October 2022
  260. MEISNER J, Baszler TV, Kuehl KE, Ramirez V, et al
    Household Transmission of SARS-CoV-2 from Humans to Pets, Washington and Idaho, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  261. CIRUELA P, Soldevila N, Garcia-Garcia JJ, Gonzalez-Peris S, et al
    Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  262. LI Y, Merbah M, Wollen-Roberts S, Beckman B, et al
    Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  263. ROEL E, Raventos B, Burn E, Pistillo A, et al
    Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  264. NYAKARAHUKA L, Whitmer S, Kyondo J, Mulei S, et al
    Crimean-Congo Hemorrhagic Fever Outbreak in Refugee Settlement during COVID-19 Pandemic, Uganda, April 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  265. YAMAYOSHI S, Iwatsuki-Horimoto K, Okuda M, Ujie M, et al
    Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  266. SODSAI P, Ittiwut C, Ruenjaiman V, Ittiwut R, et al
    TIGIT Monoallelic Nonsense Variant in Patient with Severe COVID-19 Infection, Thailand.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  267. BAZ M, Deshpande N, Mackenzie-Kludas C, Mordant F, et al
    SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  268. ROBERTSON MM, Shamsunder MG, Brazier E, Mantravadi M, et al
    Racial/Ethnic Disparities in Exposure, Disease Susceptibility, and Clinical Outcomes during COVID-19 Pandemic in National Cohort of Adults, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  269. VALLEJOS A, Baldani AEM, Gauto MA, Rueda DV, et al
    COVID-19 among Chronic Dialysis Patients after First Year of Pandemic, Argentina.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  270. KIM YY, Choe YJ, Kim J, Kim RK, et al
    Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  271. GASCH O, Badia-Cebada L, Carmezim J, Vaque M, et al
    Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  272. VALTONEN M, Waris M, Luoto R, Mjosund K, et al
    Non-SARS-CoV-2 Respiratory Viruses in Athletes at Major Winter Sport Events, 2021 and 2022.
    Emerg Infect Dis. 2022;28:2096-2099.
    PubMed     Abstract available


  273. AKHMETZHANOV AR, Cheng HY, Linton NM, Ponce L, et al
    Transmission Dynamics and Effectiveness of Control Measures during COVID-19 Surge, Taiwan, April-August 2021.
    Emerg Infect Dis. 2022;28:2051-2059.
    PubMed     Abstract available


    September 2022
  274. MARTINS-MELO FR, Castro MC, Ribeiro ALP, Heukelbach J, et al
    Deaths Related to Chagas Disease and COVID-19 Co-Infection, Brazil, March-December 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  275. LEWIS JW, Loughran J, Deng L, Varghese J, et al
    Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  276. NGUYEN NN, Houhamdi L, Delorme L, Colson P, et al
    Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  277. CHOW EJ, Casto AM, Sampoleo R, Mills MG, et al
    Human Parainfluenza Virus in Homeless Shelters before and during the COVID-19 Pandemic, Washington, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  278. COSSABOOM CM, Nyakarahuka L, Mulei S, Kyondo J, et al
    Rift Valley Fever Outbreak during COVID-19 Surge, Uganda, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  279. FUKASAWA LO, Liphaus BL, Goncalves MG, Higa FT, et al
    Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil.
    Emerg Infect Dis. 2022;28:1931-1932.
    PubMed     Abstract available


  280. KEYEL AC, Russell A, Plitnick J, Rowlands JV, et al
    SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  281. CHAN DPC, Wong NS, Wong BCK, Chan JMC, et al
    Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  282. WOLFENSBERGER A, Kufner V, Zaheri M, Zeeb M, et al
    Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


    August 2022
  283. LOPEZ-MUNOZ I, Torrella A, Lopez-Quilez O, Castillo-Zuza A, et al
    SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  284. SIM JY, Wu PS, Cheng CF, Chao YC, et al
    Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  285. SHAH MM, Winn A, Dahl RM, Kniss KL, et al
    Seasonality of Common Human Coronaviruses, United States, 2014-2021(1).
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  286. ZEEB M, Weissberg D, Rampini SK, Muller R, et al
    Identifying Contact Risks for SARS-CoV-2 Transmission to Healthcare Workers during Outbreak on COVID-19 Ward.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  287. BLOM K, Havervall S, Marking U, Norin NG, et al
    Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  288. RUFF J, Zhang Y, Kappel M, Rathi S, et al
    Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  289. MUNNINK BBO, Nijhuis RHT, Worp N, Boter M, et al
    Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  290. BERTRAN M, Amin-Chowdhury Z, Sheppard CL, Eletu S, et al
    Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England.
    Emerg Infect Dis. 2022;28:1669-1672.
    PubMed     Abstract available


  291. SEID AG, Yirko T, Sayeed S, Plipat N, et al
    Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  292. MEFSIN YM, Chen D, Bond HS, Lin Y, et al
    Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  293. ALLAN-BLITZ LT, Aboabdo B, Turner I, Klausner JD, et al
    Effect of Frequent SARS-CoV-2 Testing on Weekly Case Rates in Long-Term Care Facilities, Florida, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  294. HE D, Ali ST, Fan G, Gao D, et al
    Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  295. WERNIKE K, Bottcher J, Amelung S, Albrecht K, et al
    Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


    July 2022
  296. NORZ D, Tang HT, Emmerich P, Giersch K, et al
    Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  297. LOESCHE M, Karlson EW, Talabi O, Zhou G, et al
    Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  298. HUBERT CRJ, Acosta N, Waddell BJM, Hasing ME, et al
    Tracking Emergence and Spread of SARS-CoV-2 Omicron Variant in Large and Small Communities by Wastewater Monitoring in Alberta, Canada.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  299. KAYA D, Falender R, Radniecki T, Geniza M, et al
    Correlation between Clinical and Wastewater SARS-CoV-2 Genomic Surveillance, Oregon, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  300. PORTER SM, Hartwig AE, Bielefeldt-Ohmann H, Bosco-Lauth AM, et al
    Susceptibility of Wild Canids to SARS-CoV-2.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  301. DE OLIVEIRA-FILHO EF, Rincon-Orozco B, Jones-Cifuentes N, Pena-Lopez B, et al
    Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  302. KO YK, Murayama H, Yamasaki L, Kinoshita R, et al
    Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  303. MENG L, Murthy NC, Murthy BP, Zell E, et al
    Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons >12 Years of Age, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  304. LIM DS, Choe YJ, Man Kim Y, Lee SE, et al
    Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  305. LIN S, Deng X, Ryan I, Zhang K, et al
    COVID-19 Symptoms and Deaths among Healthcare Workers, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  306. DE VRIES M, Claassen L, Lambooij M, Leung KY, et al
    COVID-19 Vaccination Intent and Belief that Vaccination Will End the Pandemic.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  307. ARASHIRO T, Arima Y, Stucky A, Smith C, et al
    Social and Behavioral Factors Associated with Lack of Intent to Receive COVID-19 Vaccine, Japan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  308. KIM JM, Sivasubramanian G
    Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids.
    Emerg Infect Dis. 2022;28:1531-1533.
    PubMed     Abstract available


  309. KOYAMA AK, Koumans EH, Sircar K, Lavery AM, et al
    Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States.
    Emerg Infect Dis. 2022;28:1533-1536.
    PubMed     Abstract available


  310. SILVERMAN RA, Ceci A, Cohen A, Helmick M, et al
    Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men's Correctional Facility, United States.
    Emerg Infect Dis. 2022;28:1313-1320.
    PubMed     Abstract available


    June 2022
  311. NEVEJAN L, Cuypers L, Laenen L, Van Loo L, et al
    Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  312. KREMER C, Braeye T, Proesmans K, Andre E, et al
    Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  313. MAGRO M, Parriott A, Mitsunaga T, Epson E, et al
    Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  314. MATSUMURA Y, Nagao M, Yamamoto M, Tsuchido Y, et al
    Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  315. METZ AR, Bauer M, Epperly C, Stringer G, et al
    Investigation of COVID-19 Outbreak among Wildland Firefighters during Wildfire Response, Colorado, USA, 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  316. DAOUK SK, Kamau E, Adachi K, Aldrovandi GM, et al
    Zoster Meningitis in an Immunocompetent Child after COVID-19 Vaccination, California, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  317. SILA T, Sunghan J, Laochareonsuk W, Surasombatpattana S, et al
    Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July-September 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  318. MOFAZ M, Yechezkel M, Guan G, Brandeau ML, et al
    Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  319. FOWLE N, Garrett B, Floyd OL, Collins J, et al
    University-Associated SARS-CoV-2 Omicron BA.2 Infections, Maricopa County, Arizona, USA, 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  320. VIRTANEN J, Aaltonen K, Kegler K, Venkat V, et al
    Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical Disease.
    Emerg Infect Dis. 2022;28:1286-1288.
    PubMed     Abstract available


  321. BIENZLE D, Rousseau J, Marom D, MacNicol J, et al
    Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs(1).
    Emerg Infect Dis. 2022;28:1154-1162.
    PubMed     Abstract available


  322. SPENCER H, Teran RA, Barbian HJ, Love S, et al
    Multistate Outbreak of Infection with SARS-CoV-2 Omicron Variant after Event in Chicago, Illinois, USA, 2021.
    Emerg Infect Dis. 2022;28:1281-1283.
    PubMed     Abstract available


    May 2022
  323. SOFONEA MT, Roquebert B, Foulongne V, Morquin D, et al
    Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  324. LEEMAN D, Flannagan J, Chudasama D, Dack K, et al
    Effect of Returning University Students on COVID-19 Infections in England, 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  325. COLE LD, Slate M, Minneman S, Bozzella MJ, et al
    Multisystem Inflammatory Syndrome after Breakthrough SARS-CoV-2 Infection in 2 Immunized Adolescents, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  326. SHIRREFF G, Zahar JR, Cauchemez S, Temime L, et al
    Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  327. LACEK KA, Rambo-Martin BL, Batra D, Zheng XY, et al
    SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  328. CHIN AWH, Lai AMY, Peiris M, Man Poon LL, et al
    Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  329. FOURATI S, Gautier G, Chovelon M, Soulier A, et al
    Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  330. FOCOSI D, Casadevall A
    High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
    Emerg Infect Dis. 2022;28:1083.
    PubMed    


  331. MOSER W, Fahal MAH, Abualas E, Bedri S, et al
    SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan.
    Emerg Infect Dis. 2022;28:1026-1030.
    PubMed     Abstract available


  332. GRASSIA JT, Markwalter CF, O'Meara WP, Taylor SM, et al
    SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia.
    Emerg Infect Dis. 2022;28:1080-1081.
    PubMed    


  333. DE SANTIS GC, Calado RT
    High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response).
    Emerg Infect Dis. 2022;28:1083-1084.
    PubMed    


  334. FINSTERER J, Scorza FA, Scorza CA
    Guillain-Barre Syndrome Associated with COVID-19 Vaccination.
    Emerg Infect Dis. 2022;28:1079-1080.
    PubMed    


    April 2022
  335. HOGARTH F, Coffey P, Goddard L, Lewis S, et al
    Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  336. HARRIS JR, Owusu D, O'Laughlin K, Cohen AL, et al
    SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  337. NDONGO FA, Guichet E, Mimbe ED, Ndie J, et al
    Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaounde, Cameroon.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  338. SATO T, Kodama S, Kaneko K, Imai J, et al
    Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  339. SUTTON M, Radniecki TS, Kaya D, Alegre D, et al
    Detection of SARS-CoV-2 B.1.351 (Beta) Variant through Wastewater Surveillance before Case Detection in a Community, Oregon, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  340. FONSECA MHG, Pinto ACMD, Silva MFS, de Melo ACL, et al
    Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  341. NOVAZZI F, Baj A, Genoni A, Focosi D, et al
    Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  342. GU H, Ng DYM, Liu GYZ, Cheng SSM, et al
    Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  343. DEL AGUILA-MEJIA J, Wallmann R, Calvo-Montes J, Rodriguez-Lozano J, et al
    Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  344. VAUHKONEN H, Nguyen PT, Kant R, Plyusnin I, et al
    Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  345. MERCIER A, Wilkinson DA, Lebarbenchon C, Mavingui P, et al
    Spread of SARS-CoV-2 Variants on Reunion Island, France, 2021.
    Emerg Infect Dis. 2022;28:895-898.
    PubMed     Abstract available


  346. LEE HR, Choe YJ, Jang EJ, Kim J, et al
    Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea.
    Emerg Infect Dis. 2022;28:901-903.
    PubMed     Abstract available


  347. GROME HN, Meyer B, Read E, Buchanan M, et al
    SARS-CoV-2 Outbreak among Malayan Tigers and Humans, Tennessee, USA, 2020.
    Emerg Infect Dis. 2022;28:833-836.
    PubMed     Abstract available


  348. WINGLEE K, Hill AN, Langer AJ, Self JL, et al
    Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020.
    Emerg Infect Dis. 2022;28:820-827.
    PubMed     Abstract available


  349. BEN LAKHAL H, Cachinho JB, Kalfon P, Naas T, et al
    Bordetella hinzii Pneumonia in Patient with SARS-CoV-2 Infection.
    Emerg Infect Dis. 2022;28:844-847.
    PubMed     Abstract available


  350. RASMUSSEN LD, Richter SR, Midgley SE, Franck KT, et al
    Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  351. GLATMAN-FREEDMAN A, Bromberg M, Hershkovitz Y, Sefty H, et al
    Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


    March 2022
  352. PEDERSEN RM, Bang LL, Madsen LW, Sydenham TV, et al
    Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  353. YU AT, Hughes B, Wolfe MK, Leon T, et al
    Estimating Relative Abundance of 2 SARS-CoV-2 Variants through Wastewater Surveillance at 2 Large Metropolitan Sites, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  354. JENNY-AVITAL ER, Howe RA
    Severe Multisystem Inflammatory Symptoms in 2 Adults after Short Interval between COVID-19 and Subsequent Vaccination.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  355. KLEYNHANS J, Tempia S, Wolter N, von Gottberg A, et al
    SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  356. BBOSA N, Ssemwanga D, Namagembe H, Kiiza R, et al
    Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  357. TAKAHASHI K, Ishikane M, Ujiie M, Iwamoto N, et al
    Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  358. JAIN E, Donowitz JR, Aarons E, Marshall BC, et al
    Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  359. KOOPSEN J, van Ewijk CE, Bavalia R, Cornelissen A, et al
    Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  360. VAN GEMERT C, Tarivonda L, Tapo PS, Natuman S, et al
    Mathematical Modeling for Removing Border Entry and Quarantine Requirements for COVID-19, Vanuatu.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  361. TOBER-LAU P, Gruell H, Vanshylla K, Koch WM, et al
    Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


    February 2022
  362. MURTHY NC, Zell E, Fast HE, Murthy BP, et al
    Disparities in First Dose COVID-19 Vaccination Coverage among Children 5-11 Years of Age, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.